Cargando…
Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities
The ubiquitin proteasome system (UPS) plays a role in the regulation of most cellular pathways, and its deregulation has been implicated in a wide range of human pathologies that include cancer, neurodegenerative and immunological disorders and viral infections. Targeting the UPS by small molecular...
Autores principales: | Landré, Vivien, Rotblat, Barak, Melino, Sonia, Bernassola, Francesca, Melino, Gerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226663/ https://www.ncbi.nlm.nih.gov/pubmed/25237759 |
Ejemplares similares
-
Emerging roles of the HECT-type E3 ubiquitin ligases in hematological malignancies
por: Delvecchio, Vincenza Simona, et al.
Publicado: (2021) -
Emerging roles of HECT‐type E3 ubiquitin ligases in autophagy regulation
por: Melino, Gerry, et al.
Publicado: (2019) -
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy
por: Rossi, M, et al.
Publicado: (2014) -
The Impact of the Ubiquitin System in the Pathogenesis of Squamous Cell Carcinomas
por: Gatti, Veronica, et al.
Publicado: (2020) -
Polypharmacology of small molecules targeting the ubiquitin–proteasome and ubiquitin-like systems
por: Amelio, Ivano, et al.
Publicado: (2015)